{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T05:11:30Z","timestamp":1697778690336},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T00:00:00Z","timestamp":1694995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T00:00:00Z","timestamp":1694995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmologie"],"published-print":{"date-parts":[[2023,10]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title><jats:sec>\n                <jats:title>Operationsziel<\/jats:title>\n                <jats:p>Ziel dieser Operationstechnik ist die modifizierte Anlage eines PAUL\u00ae-Implantates (Fa. Advanced Ophthalmic Innovations, Singapur) in Augen nach PreserFlo\u00ae MicroShunt(Fa. Santen, Osaka, Japan)-Implantatversagen zur bestm\u00f6glichen Augeninnendruckeinstellung.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Indikationen<\/jats:title>\n                <jats:p>Die Operationsindikation bezieht sich auf komplexere Glaukome, die bereits erfolglos mittels PreserFlo\u00ae MicroShunt  operiert wurden.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Operationstechnik<\/jats:title>\n                <jats:p>Die Besonderheiten des M\u00fcnsteraner Standards sind die Wahl des Operationsgebietes und der Verzicht auf eine weitere Tunnelneuanlage. Die Patienten erhalten eine PAUL\u00ae-Implantation im selben Quadranten der zuvor erfolgten PreserFlo\u00ae MicroShunt-Implantation (superior-temporal). Nach Pr\u00e4paration der Bindehaut, Priming des PAUL\u00ae-Implantates mittels Prolene\u20116.0\u2011Faden und Fixierung der Platte erfolgt die Explantation des PreserFlo\u00ae MicroShunt. Um die Implantation des PAUL\u00ae-Schlauchs durch den alten 25-Gauge-Tunnel zu vollziehen, wird dieser mittels Irisspatel unter Vorderkammerstellung seitlich dilatiert. Anhand eines Operationsvideos, das online zur Verf\u00fcgung steht, wird die Operationstechnik detailliert dargestellt.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Vorteile des M\u00fcnsteraner Standards<\/jats:title>\n                <jats:p>Der operative Zugang temporal-superior verspricht ein leichteres Handling, der Verzicht auf eine Tunnelneuanlage spart effektive Operationszeit. Weniger Endothelzellverluste bei nur einem liegenden Schlauch im Vergleich zu 2\u00a0Vorderkammerschl\u00e4uchen sind potenziell zu erwarten.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00347-023-01914-5","type":"journal-article","created":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T14:02:20Z","timestamp":1695045740000},"page":"1056-1059","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["M\u00fcnsteraner Standard: modifizierte PAUL\u00ae-Implantation bei Zustand nach PreserFlo\u00ae MicroShunt-Implantation. Videobeitrag","M\u00fcnster standard: modified Paul\u00ae implantation in a condition following Preserflo\u00ae MicroShunt implantation. Video article"],"prefix":"10.1007","volume":"120","author":[{"given":"Viktoria C.","family":"Br\u00fccher","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julian A.","family":"Zimmermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens J.","family":"Storp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Eter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,9,18]]},"reference":[{"issue":"3","key":"1914_CR1","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1136\/bjo.2005.081224","volume":"90","author":"HA Quigley","year":"2006","unstructured":"Quigley\u00a0HA, Broman\u00a0AT (2006) The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol 90(3):262\u2013267","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"1914_CR2","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.ophtha.2014.08.043","volume":"122","author":"DL Budenz","year":"2015","unstructured":"Budenz\u00a0DL, Barton\u00a0K, Gedde\u00a0SJ et al (2015) Five-year treatment outcomes in the Ahmed Baerveldt comparison study. Ophthalmology 122(2):308\u2013316","journal-title":"Ophthalmology"},{"key":"1914_CR3","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.ajo.2017.01.003","volume":"176","author":"PG Christakis","year":"2017","unstructured":"Christakis\u00a0PG, Zhang\u00a0D, Budenz\u00a0DL et al (2017) Five-year pooled data analysis of the Ahmed Baerveldt comparison study and the Ahmed versus Baerveldt study. Am J Ophthalmol 176:118\u2013126","journal-title":"Am J Ophthalmol"},{"issue":"10","key":"1914_CR4","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1016\/j.ophtha.2016.06.035","volume":"123","author":"PG Christakis","year":"2016","unstructured":"Christakis\u00a0PG, Kalenak\u00a0JW, Tsai\u00a0JC et al (2016) The Ahmed versus Baerveldt study: five-year treatment outcomes. Ophthalmology 123(10):2093\u20132102","journal-title":"Ophthalmology"},{"issue":"5","key":"1914_CR5","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.ajo.2011.10.026","volume":"153","author":"SJ Gedde","year":"2012","unstructured":"Gedde\u00a0SJ, Schiffman\u00a0JC, Feuer\u00a0WJ et al (2012) Treatment outcomes in the Tube Versus Trabeculectomy (TVT) study after five years of follow-up. Am J Ophthalmol 153(5):789\u2013803.e2","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"1914_CR6","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.ogla.2020.05.001","volume":"3","author":"V Koh","year":"2020","unstructured":"Koh\u00a0V, Chew\u00a0P, Triolo\u00a0G et\u00a0al (2020) Treatment outcomes using the PAUL glaucoma implant to control Intraocular pressure in eyes with refractory glaucoma. Ophthalmol Glaucoma 3(5):350\u2013359","journal-title":"Ophthalmol Glaucoma"},{"issue":"10","key":"1914_CR7","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1038\/s41433-021-01737-1","volume":"36","author":"NA Vallabh","year":"2021","unstructured":"Vallabh\u00a0NA, Mason\u00a0F, Yu\u00a0JTS et\u00a0al (2021) Surgical technique, perioperative management and early outcome data of the PAUL\u00ae glaucoma drainage device. Eye 36(10):1905\u20131910","journal-title":"Eye"},{"issue":"3","key":"1914_CR8","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1097\/IJG.0000000000001969","volume":"31","author":"P Jos\u00e9","year":"2021","unstructured":"Jos\u00e9\u00a0P, Bar\u00e3o\u00a0RC, Teixeira\u00a0FJ et al (2021) One-year efficacy and safety of the PAUL glaucoma implant using a\u00a0standardized surgical protocol. J\u00a0Glaucoma 31(3):201\u2013205","journal-title":"J Glaucoma"}],"container-title":["Die Ophthalmologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-023-01914-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00347-023-01914-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-023-01914-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T15:04:51Z","timestamp":1697727891000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00347-023-01914-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,18]]},"references-count":8,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["1914"],"URL":"https:\/\/doi.org\/10.1007\/s00347-023-01914-5","relation":{},"ISSN":["2731-720X","2731-7218"],"issn-type":[{"value":"2731-720X","type":"print"},{"value":"2731-7218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,18]]},"assertion":[{"value":"1 August 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"V.C.\u00a0Br\u00fccher weist auf folgende Beziehungen hin: Invited speaker f\u00fcr FCI Paris\/Frankreich. J.A.\u00a0Zimmermann, J.J.\u00a0Storp und N.\u00a0Eter geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patient\/-innen zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern\/Vertreterinnen eine schriftliche Einwilligung vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}